ADA Scientific Sessions 2026 Abstract

Efficacy and Hypoglycemia Outcomes with Once-Weekly IcoSema vs. Comparators in T2D by Baseline A1C: COMBINE 1–3

By Viswanathan Mohan, Raluca Maltesen, Laura Pletsch-Borba, Linong Ji

Trial in peopleInterventions

The paper

Viswanathan Mohan, Raluca Maltesen, Laura Pletsch-Borba, Linong Ji

Chennai

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1738-P

doi.org/10.2337/db26-1738-p

Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial